Hims & Hers Health (NYSE:HIMS) COO Sells $504,762.50 in Stock

Hims & Hers Health, Inc. (NYSE:HIMS) COO Michael Chi sold 13,750 shares of the company’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $36.71, for a total transaction of $504,762.50. Following the completion of the sale, the chief operating officer directly owned 305,161 shares in the company, valued at approximately $11,202,460.31. The trade was a 4.31% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Michael Chi also recently made the following trade(s):

• On Friday, October 10th, Michael Chi sold 900 shares of Hims & Hers Health stock. The stock was sold at an average price of $58.25, for a total transaction of $52,425.00.
• On Wednesday, September 24th, Michael Chi sold 2,100 shares of Hims & Hers Health stock. The shares were sold at an average price of $56.52, for a total value of $118,692.00.

Hims & Hers Health Price Performance

Shares of HIMS stock traded down $0.23 during trading hours on Thursday, hitting $34.74. The company had a trading volume of 11,410,870 shares, compared to its average volume of 30,867,883. Hims & Hers Health, Inc. has a 12 month low of $23.97 and a 12 month high of $72.98. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.64 and a current ratio of 1.88. The firm’s fifty day moving average is $42.69 and its 200 day moving average is $48.78. The firm has a market capitalization of $7.91 billion, a price-to-earnings ratio of 64.33, a PEG ratio of 7.29 and a beta of 2.41.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, November 3rd. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). The company had revenue of $598.98 million for the quarter, compared to the consensus estimate of $578.99 million. Hims & Hers Health had a return on equity of 24.67% and a net margin of 6.05%.Hims & Hers Health’s quarterly revenue was up 49.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.32 EPS. On average, sell-side analysts predict that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Hims & Hers Health announced that its Board of Directors has approved a stock buyback plan on Monday, November 17th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 3% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Barclays initiated coverage on shares of Hims & Hers Health in a research report on Monday, December 8th. They issued an “overweight” rating and a $48.00 price target on the stock. Leerink Partnrs raised Hims & Hers Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, December 4th. BTIG Research reaffirmed a “buy” rating and set a $85.00 price target on shares of Hims & Hers Health in a report on Tuesday, November 4th. Bank of America increased their target price on Hims & Hers Health from $28.00 to $32.00 and gave the stock an “underperform” rating in a report on Tuesday, November 4th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Hims & Hers Health in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, Hims & Hers Health presently has a consensus rating of “Hold” and an average price target of $45.50.

Hedge Funds Weigh In On Hims & Hers Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Virtus Advisers LLC bought a new stake in shares of Hims & Hers Health during the 2nd quarter valued at $26,000. Quent Capital LLC bought a new stake in Hims & Hers Health in the third quarter valued at about $28,000. Binnacle Investments Inc acquired a new position in Hims & Hers Health in the third quarter valued at about $28,000. Quaker Wealth Management LLC bought a new position in Hims & Hers Health during the second quarter worth about $29,000. Finally, Bessemer Group Inc. increased its stake in shares of Hims & Hers Health by 105.8% in the 2nd quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after acquiring an additional 312 shares during the last quarter. 63.52% of the stock is owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.